Porvair (PRV) H2 2024 earnings summary

Executive summary

• Achieved record revenues and profits for the year, with net cash at £13.7 million after significant investment.

• Strategy unchanged for 20 years, focusing on niche, engineered products with strong annuity sales and barriers to entry.

• Consistent earnings growth targeted, with management incentivized on ESG metrics and a focus on organic growth and selective acquisitions.

• Sector volatility persisted, with robust performance in aerospace and petrochemical, but de-stocking impacted laboratory and industrial consumables.

• CEO transition underway, with Hooman Caman Javvi set to succeed Ben Stocks.

Financial highlights

• Group revenue up 9% year-over-year to £192.6 million; constant currency growth was 13%.

• Adjusted profit before tax up 6% to £22.7 million; adjusted EPS up 4% to £0.386.

• Operating profit rose 8% to £24.5 million, with margin at 12.7%, including a £0.9 million hurricane charge.

• Operating cash flow before working capital movement was £29.5 million; cash from operations up 7% to £25.7 million.

• Year-end net cash of £13.7 million, no debt, after £15.3 million spent on acquisitions and CapEx.

Outlook and guidance

• Near-term described as a transition year with sector volatility and economic uncertainty, but long-term growth drivers and strategic outlook remain strong.

• CapEx expected to exceed £6 million in the coming year, mainly for the Hendersonville aluminum cast shop upgrade.

• Surplus cash generation of £15 million per annum supports ongoing investment and growth.